Stephen Hoge's most recent trade in Moderna Inc was a trade of 160,009 Common Stock done at an average price of $48.8 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 48.84 per share. | 23 Feb 2026 | 160,009 | 1,457,427 (0%) | 0% | 48.8 | 7,814,840 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2026 | 111,679 | 111,678 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 23 Feb 2026 | 111,679 | 1,569,106 (0%) | 0% | 19.2 | 2,138,653 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 23 Feb 2026 | 48,330 | 1,617,436 (0%) | 0% | 19.2 | 925,520 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2026 | 48,330 | 48,330 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 4,884 | 1,459,789 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 11 Feb 2026 | 2,362 | 1,457,427 (0%) | 0% | 42.0 | 99,180 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 652 | 1,455,221 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 652 | 652 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 01 Dec 2025 | 316 | 1,454,905 (0%) | 0% | 26.0 | 8,210 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 1,437 | 12,931 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 1,437 | 1,454,949 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.75 per share. | 26 Nov 2025 | 695 | 1,454,254 (0%) | 0% | 24.7 | 17,201 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 610 | 1,454,864 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 610 | 3,053 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.01 per share. | 26 Nov 2025 | 295 | 1,454,569 (0%) | 0% | 25.0 | 7,378 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 651 | 1,453,827 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2025 | 651 | 1,304 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.47 per share. | 29 Aug 2025 | 315 | 1,453,512 (0%) | 0% | 24.5 | 7,708 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 1,437 | 14,368 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 1,437 | 1,453,556 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.73 per share. | 27 Aug 2025 | 695 | 1,452,861 (0%) | 0% | 24.7 | 17,187 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 611 | 1,453,472 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 611 | 3,663 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.10 per share. | 27 Aug 2025 | 296 | 1,453,176 (0%) | 0% | 25.1 | 7,430 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 652 | 1,452,435 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 652 | 1,955 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.93 per share. | 30 May 2025 | 316 | 1,452,119 (0%) | 0% | 26.9 | 8,510 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 1,436 | 15,805 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 1,436 | 1,452,163 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.26 per share. | 27 May 2025 | 695 | 1,451,468 (0%) | 0% | 26.3 | 18,251 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 610 | 4,274 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 610 | 1,452,078 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.76 per share. | 27 May 2025 | 295 | 1,451,783 (0%) | 0% | 26.8 | 7,894 | Common Stock |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 238,043 | 238,043 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 148,524 | 148,524 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 652 | 2,607 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 652 | 1,450,728 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 611 | 4,884 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 611 | 1,451,023 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 316 | 1,450,412 (0%) | 0% | 31.1 | 9,824 | Common Stock |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 296 | 1,450,727 (0%) | 0% | 31.1 | 9,203 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,746 | 17,241 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,746 | 1,452,855 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 2,779 | 1,450,076 (0%) | 0% | 33.6 | 93,319 | Common Stock |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 5,734 | 1,449,880 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.93 per share. | 12 Feb 2025 | 2,771 | 1,447,109 (0%) | 0% | 30.9 | 85,707 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 523 | 0 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 523 | 1,444,427 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.61 per share. | 07 Feb 2025 | 281 | 1,444,146 (0%) | 0% | 33.6 | 9,444 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 651 | 1,444,218 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 651 | 3,259 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 43.30 per share. | 02 Dec 2024 | 314 | 1,443,904 (0%) | 0% | 43.3 | 13,595 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 610 | 1,443,858 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 610 | 5,495 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 291 | 1,443,567 (0%) | 0% | 42.8 | 12,452 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 523 | 1,443,525 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 523 | 523 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 08 Nov 2024 | 277 | 1,443,248 (0%) | 0% | 46.1 | 12,771 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 652 | 1,443,320 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 652 | 3,910 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 76.99 per share. | 30 Aug 2024 | 318 | 1,443,002 (0%) | 0% | 77.0 | 24,483 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 611 | 1,442,968 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 611 | 6,105 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 78.03 per share. | 28 Aug 2024 | 300 | 1,442,668 (0%) | 0% | 78.0 | 23,408 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 522 | 1,442,611 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 522 | 1,046 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 84.11 per share. | 09 Aug 2024 | 254 | 1,442,357 (0%) | 0% | 84.1 | 21,363 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 121.12 per share. | 15 Jul 2024 | 15,000 | 1,442,089 (0%) | 0% | 121.1 | 1,816,800 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 17 Jun 2024 | 15,000 | 1,457,089 (0%) | 0% | 138.2 | 2,072,400 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 651 | 1,472,428 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 651 | 4,562 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 339 | 1,472,089 (0%) | 0% | 140.7 | 47,704 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 610 | 1,472,118 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 610 | 6,716 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 341 | 1,471,777 (0%) | 0% | 144.5 | 49,276 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 127.49 per share. | 15 May 2024 | 15,000 | 1,471,508 (0%) | 0% | 127.5 | 1,912,350 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 522 | 1,568 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 522 | 1,486,763 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 120.96 per share. | 09 May 2024 | 255 | 1,486,508 (0%) | 0% | 121.0 | 30,844 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 105.02 per share. | 15 Apr 2024 | 15,000 | 1,486,241 (0%) | 0% | 105.0 | 1,575,300 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 103.17 per share. | 15 Mar 2024 | 15,000 | 1,501,241 (0%) | 0% | 103.2 | 1,547,550 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 652 | 1,516,550 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 652 | 5,213 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 94.34 per share. | 01 Mar 2024 | 309 | 1,516,241 (0%) | 0% | 94.3 | 29,151 | Common Stock |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,442 | 1,518,286 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,442 | 7,326 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,411 | 1,515,844 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,411 | 0 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 94.57 per share. | 28 Feb 2024 | 2,388 | 1,515,898 (0%) | 0% | 94.6 | 225,838 | Common Stock |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 43,894 | 43,894 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 22,987 | 22,987 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 22 Feb 2024 | 15,000 | 1,513,433 (0%) | 0% | 100 | 1,500,000 | Common Stock |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,694 | 1,538,975 (0%) | 0% | 0 | Common Stock | |
| Moderna | Hoge Stephen | President | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 14 Feb 2024 | 10,542 | 1,528,433 (0%) | 0% | 88.9 | 936,981 | Common Stock |
| Moderna | Hoge Stephen | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 522 | 1,516,585 (0%) | 0% | - | Common Stock | |
| Moderna | Stephen Hoge | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 522 | 2,090 | - | - | Restricted Stock Units | |
| Moderna | Hoge Stephen | President | Sale of securities on an exchange or to another person at price $ 86.23 per share. | 09 Feb 2024 | 304 | 1,516,281 (0%) | 0% | 86.2 | 26,214 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 103.90 per share. | 16 Jan 2024 | 15,000 | 1,516,063 (0%) | 0% | 103.9 | 1,558,500 | Common Stock |
| Moderna | Stephen Hoge | President | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 27 Dec 2023 | 45,000 | 1,531,063 (0%) | 0% | 100.0 | 4,500,450 | Common Stock |
| Moderna | Hoge Stephen | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 651 | 1,576,372 (0%) | 0% | - | Common Stock |